TCTC Holdings’s Takeda Pharmaceutical TAK Stock Holding History

TCTC Holdings’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-372	Closed	-$5.8K	–	545
2025 Q4	$5.8K	Hold	372	–	–	﹤0.01%	529
2025 Q3	$5.45K	Hold	372	–	–	﹤0.01%	532
2025 Q2	$5.75K	Hold	372	–	–	﹤0.01%	564
2025 Q1	$5.53K	Hold	372	–	–	﹤0.01%	594
2024 Q4	$4.92K	Hold	372	–	–	﹤0.01%	622
2024 Q3	$5.29K	Hold	372	–	–	﹤0.01%	457
2024 Q2	$4.81K	Hold	372	–	–	﹤0.01%	468
2024 Q1	$5.17K	Hold	372	–	–	﹤0.01%	474
2023 Q4	$5.31K	Hold	372	–	–	﹤0.01%	436
2023 Q3	$5.75K	Hold	372	–	–	﹤0.01%	382
2023 Q2	$5.84K	Sell	372 -5	-1%	-$82	﹤0.01%	383
2023 Q1	$6.21K	Buy	377 +5	+1%	+$80	﹤0.01%	418
2022 Q4	$5.8K	Hold	372	–	–	﹤0.01%	384
2022 Q3	$5K	Hold	372	–	–	﹤0.01%	381
2022 Q2	$5K	Hold	372	–	–	﹤0.01%	376
2022 Q1	$5K	Hold	372	–	–	﹤0.01%	385
2021 Q4	$5K	Hold	372	–	–	﹤0.01%	416
2021 Q3	$6K	Hold	372	–	–	﹤0.01%	417
2021 Q2	$6K	Sell	372 -976	-72%	-$16.6K	﹤0.01%	374
2021 Q1	$25K	Hold	1,348	–	–	﹤0.01%	308
2020 Q4	$25K	Hold	1,348	–	–	﹤0.01%	298
2020 Q3	$24K	Hold	1,348	–	–	﹤0.01%	285
2020 Q2	$24K	Buy	+1,348	New	+$24.2K	﹤0.01%	282

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCTC Holdings's TAK Position: Q1 2026 in Review

TCTC Holdings sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 372 shares — an estimated $5.8K sold.

TCTC Holdings first reported a position in TAK in Q2 2020 and held it in 23 quarters. The position peaked at $25K in Q1 2021. 361 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

TCTC Holdings reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
TCTC Holdings sold 372 Takeda Pharmaceutical shares in Q1 2026, an estimated $5.8K.
TCTC Holdings first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 23 quarters.
TCTC Holdings's Takeda Pharmaceutical position peaked at $25K in Q1 2021.
361 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.